Company · CIK 1626971
Corvus Pharmaceuticals, Inc.
| CIK | 1626971 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | CRVS (Nasdaq) |
| First annual or quarterly report | 2016-05-05 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-294272 | 2026-03-13 | 2026-03-13 | 2 | |
| 333-281318 | 2024-08-06 | 2026-01-23 | 4 | |
| 333-270921 | 2023-03-29 | 2024-05-03 | 3 | |
| 333-237040 | 2020-03-09 | 2021-11-02 | 6 | |
| 333-217102 | 2017-04-03 | 2018-03-09 | 6 | |
| 333-208850 | 2016-01-04 | 2016-03-24 | 5 |
Filings
27| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-13 | 424B5Shelf takedown | 333-294272 | 0001104659-26-027382 |
| 2026-03-13 | S-3ASRShelf registered | 333-294272 | 0001104659-26-027362 |
| 2026-01-23 | 424B5Shelf takedown | 333-281318 | 0001104659-26-005967 |
| 2026-01-20 | 424B5Shelf takedown | 333-281318 | 0001104659-26-005113 |
| 2024-08-15 | EFFECTDeclared effective | 333-281318 | 9999999995-24-002546 |
| 2024-08-06 | S-3Shelf registered | 333-281318 | 0001193125-24-195009 |
| 2024-05-03 | 424B5Shelf takedown | 333-270921 | 0001193125-24-130685 |
| 2023-05-08 | EFFECTDeclared effective | 333-270921 | 9999999995-23-001332 |
| 2023-03-29 | S-3Shelf registered | 333-270921 | 0001193125-23-082535 |
| 2021-11-02 | 424B5Shelf takedown | 333-237040 | 0001104659-21-132576 |
| 2021-02-12 | 424B5Shelf takedown | 333-237040 | 0001104659-21-021309 |
| 2021-02-11 | 424B5Shelf takedown | 333-237040 | 0001104659-21-020808 |
| 2020-03-20 | 424B5Shelf takedown | 333-237040 | 0001104659-20-036930 |
| 2020-03-19 | EFFECTDeclared effective | 333-237040 | 9999999995-20-000598 |
| 2020-03-09 | S-3Shelf registered | 333-237040 | 0001104659-20-030827 |
| 2018-03-09 | 424B5Shelf takedown | 333-217102 | 0001104659-18-016051 |
| 2018-03-07 | 424B5Shelf takedown | 333-217102 | 0001104659-18-015593 |
| 2017-09-21 | 424B5Shelf takedown | 333-217102 | 0001104659-17-058179 |
| 2017-09-20 | 424B4Final prospectus | 333-217102 | 0001104659-17-058099 |
| 2017-06-09 | EFFECTDeclared effective | 333-217102 | 9999999995-17-001489 |
| 2017-04-03 | S-3Shelf registered | 333-217102 | 0001104659-17-020803 |
| 2016-03-24 | 424B4Final prospectus | 333-208850 | 0001047469-16-011550 |
| 2016-03-22 | EFFECTDeclared effective | 333-208850 | 9999999995-16-004016 |
| 2016-03-10 | S-1/AAmendment | 333-208850 | 0001047469-16-010993 |
| 2016-02-08 | S-1/AAmendment | 333-208850 | 0001047469-16-010056 |
| 2016-01-04 | S-1Registration filed | 333-208850 | 0001047469-16-009531 |
| 2015-11-06 | DRSDraft made public | 377-01201 | 0000912057-15-000384 |